Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced…

Overview of attention for article published in Frontiers in Pharmacology, February 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,852 followers.

New Research: Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients https://t.co/QeSoKQIM40 #pharmacology

22 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.